Tokyo, Feb. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060579) titled 'Efficacy of a Diabetes Onset Prevention App System Utilizing Continuous Glucose Monitoring and Artificial Intelligence in Individuals at High Risk for Type 2 Diabetes' on Feb. 13.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Active
Primary Sponsor:
Institute - Niigata University
Condition:
Condition - Prediabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - As existing evidence is limited to improvements in surrogate markers, this study will conduct a 1-year randomized ...